Lofexidine Tablet, Coated
Product Images NDC 14445-146

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lofexidine (NDC 14445-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indoco Remedies Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lofexidine-structure (Lofexidien Structure)

FDA Label Image

Carton-label-96 (Lofexidine Carton Label)

This is a pharmaceutical label for Lofexidine tablets. It provides information on storage conditions, active ingredients, manufacturer details, and safety warnings. The tablets contain Lofexidine 0.18 mg and should be stored at 25°C (77°F) with excursions allowed from 15° to 30°C (59° to 86°F). It emphasizes keeping the tablets away from heat and moisture and keeping them out of reach of children. The manufacturer is Indoco Remedies Ltd.*

FDA Label Image

Container-label-96 (Lofexidine Container Label)

FDA Label Image

Lofexidine-fig-1 (Lofexidine Fig 1)

This text provides information on the proportion of subjects completing treatment period for two different doses of Lofexidine, 2.16mg and 2.88mg, on study day. The data can be used to analyze the completion rates for the treatment periods of these doses.*

FDA Label Image

Lofexidine-fig-2 (Lofexidine Fig 2)

FDA Label Image

Lofexidine-fig-3 (Lofexidine Fig 3)

Lofexidine 2.88 mg is a medication or substance being compared to a placebo in a study. The dosage of Lofexidine in this study is specified as 2.88 mg.*

FDA Label Image

Lofexidine-fig-4 (Lofexidine Fig 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.